Neurodevelopmental and audiological outcome of healthy term newborns with moderately severe non-haemolytic hyperbilirubinemia

Journal of Paediatrics and Child Health

Volumn 46, Issue 10, 2010, Pages 588-591

  Heimler, Ruth ^a   Sasidharan, Ponthenkandath ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

audiological outcome; hyperbilirubinemia; neurodevelopmental outcome; newborns

Indexed keywords

BILIRUBIN;

ARTICLE; AUDIOLOGY; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONFOUNDING VARIABLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; GILBERT DISEASE; HEARING TEST; HOSPITAL READMISSION; HUMAN; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEWBORN; NEWBORN JAUNDICE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SPEECH ANALYSIS; STATISTICAL SIGNIFICANCE;

BILIRUBIN; BRAIN; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HEARING LOSS; HUMANS; HYPERBILIRUBINEMIA; INFANT; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; SEVERITY OF ILLNESS INDEX;

EID: 78349276977     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2010.01800.x     Document Type: Article

References (29)

1. Kliegman RN, Behrman RE,. Kernicterus. In:, Behrman RE, Kliegman RN, eds. Textbook of Pediatrics, Vol. 14. Philadelphia: WB Saunders, 1992; 479-81.
2. Newman TB, Maisels MJ,. Does hyperbilirubinemia damage the brain? Clin. Perinatol. 1990; 17: 331-58.
3. Newman TB, Maisels MJ,. Evaluation of treatment of jaundice in the term Newborn: a kinder, gentler approach. Pediatric 1992; 89: 809-18.
4. Newman TB, Klebanoff MA,. Neonatal hyperbilirubinemia and long- term outcome: another look at the collaborative perinatal project. Pediatrics 1994; 91: 651-7.
5. American Academy of Pediatrics. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994; 94: 558-65.
6. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
7. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S,. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J. Obstet. Gynecol. Neonatal. Nurs. 2006; 35: 444-55.
8. Johnson LJ,. Hyperbilirubinemia in the term infant: when to worry, when to treat. NY State J. Med. 1991; 483-89.
9. Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R,. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics 1991; 88: 828-33.
10. Maisels MJ, Newman TB,. Kernicterus in otherwise healthy breast-fed term newborns. Pediatrics 1995; 96: 730-33.
11. Johnson LH, Bhutani VK,. System based approach to management of neonatal jaundice and prevention of kernicterus. J. Pediatr. 2002; 140: 396-403.
12. Heimler R, Shekhawat P, Hoffmann RG, Chetty VK, Sasidharan P,. Hospital readmission and morbidity following early newborn discharge. Clin. Pediatr. 1998; 37: 609-16.
13. Bayley N,. The Revised Bailey Scale. San Antonio: Harcourt Brace & Company, 1993.
14. Zimmerman IL, Steiner VG, Pond RE,. Preschool Language Scale 3 Standardization Edition. New York: The Psychological Corporation, Harcourt Brace and Company, 1991.
15. Conolly AM, Volpe JJ,. Clinical features of bilirubin encephalopathy. Clin. Perinat. 1990; 2: 371-79.
16. Rubin RA, Barlow B, Fisch RO,. Neonatal serum bilirubin levels related to cognitive development at age 4 through 7 years. J. Pediatr. 1979; 94: 601-4.
17. Nilsen ST, Finne PH, Bergsjo P, Stamnes O,. Males with neonatal hyperbilirubinemia examined at 18 years of age. Acta Paediatr. Scand. 1984; 73: 176-80.
18. Osmert E, Erdem G, Topcu M, et al. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr. 1996; 85: 1440-44.
19. Chisin R, Perlman M, Sohmer H,. Cochlear and brain stem responses in hearing loss following neonatal hyperbilirubinemia. Ann. Otol. 1979; 88: 352-57.
20. Johnson L, Winchester R, Atkins T,. Central hearing and communication disorders and hyperbilirubinemia. Pediatr. Res. 1990; 27: 210A.
21. Sourani-Lansing I, Woltil HA, Hadders-Algra M,. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain? Pediatr. Res. 2001; 50: 701-05.
22. Grimmer I, Berger-Jones K, Buhrer C, Brandl U, Obladen M,. Late neurological sequelae of non-hemolytic hypeerbilirubinemia of healthy term newborns. Acta Paediatr. 1999; 88: 661-63.
23. Amiel-Tison C, Stewart A,. Follow-up studies during the first five years of life: a pervasive assessment of neurological function. Arch. Dis. Child. 1999; 64: 496-502.
24. Towen BCL,. Examination of the Child with Minor Neurological Dysfunction, 2nd edn. Philadelphia: Spastic International Medical Publications, Publisher JB Lippincot Company, 1979.
25. Yilmaz Y, Karudeniz L, Yildiz F, Degirmencis Y, Say A,. Neurological prognosis in term newborns with indirect hyperbilirubinemia. Indian Pediatr. 2001; 38: 165-68.
26. Newman TB, Liljestrand P, Jeremy RJ, et al.; Jaundice and Infant Feeding Study Team. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N. Engl. J. Med. 2006; 354: 1889-900.
27. Odell GB,. Influence of binding on the toxicity of bilirubin. Ann. N. Y. Acad. Sci. 1973; 226: 225-37.
28. Wenneberg RP, Hance AJ,. Experimental bilirubin encephalopathy: importance of total bilirubin protein binding, and blood-brain barrier. Pediatr. Res. 1986; 20: 789-92.
29. Lassman FM, LaBenz PJ, LaBenz ES,. Hearing. In:, Lassman FM, ed. Early Correlates of Speech, Language and Hearing. Littleton, MA: PSG Publishing Company, 1980; 120.